11. In the opinion of the investigator, the patient has not derived significant therapeutic benefit from 2 or more ADHD therapies given with an adequate dose and duration in adulthood (age 18 or older); i.e., 1 failed course of treatment is acceptable, but 2 failed courses of treatment are not acceptable.